Author:
Bramhall S R,Hallissey M T,Whiting J,Scholefield J,Tierney G,Stuart R C,Hawkins R E,McCulloch P,Maughan T,Brown P D,Baillet M,Fielding J W L
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Agouron (2000) Pfizer discontinues phase III trials of prinomastat in advanced cancers but continues multiple phase II trials. San Diego: Agouron Pharmaceuticals Inc
2. Bramhall SR, Rosemurgy A, Brown PD, Bowry C and Buckels JAC (2001) Marimastat as first-line therapy for patients with unresectable pancreatic cancer – a randomized trial. J Clin Oncol 19: 3447–3455
3. British Biotech plc (2000a) Results of marimastat study 131 in glioblastoma multiforme. Oxford: British Biotech plc
4. British Biotech plc (2000b) Results of marimastat study 186 in patients with advanced ovarian cancer. Oxford: British Biotech plc
5. British Biotech plc (2001) Results of marimastat study 140 in patients with small cell lung cancer. Oxford: British Biotech plc
Cited by
230 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献